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ABSTRACT Prior studies have identified a subset of den-
dritic cells in human blood, as well as their stimulatory function
for T-cell-mediated immune responses. However research has
been limited by difficulties in isolation, since dendritic cells
make up only 0.1-1% of blood mononuclear cells. We present
a protocol that reliably yields preparations that are >80-90%
pure. The method relies on the sequential depletion of the
major cell types in blood and simultaneously provides T cells,
monocytes, and B plus natural killer cells for comparison with
dendritic cells. The last step in the procedure is the removal of
residual contaminants on the basis of expression of a CD45R
epitope. The enrichment of dendritic cells is evident by three
criteria, each of which is related to the surface of these
antigen-presenting cells. (i) All dendritic cells are motile,
constantly forming large lamellipodia or veils. (ii) When ana-
lyzed with a large panel of monoclonal antibodies and the
FACS, the cells express high levels of all known polymorphic
major histocompatibility complex gene products, as well as a
distinct combination of receptors and adhesion molecules.
Unlike monocytes, for example, dendritic cells lack Fc recep-
tors and the colony-stimulating factor 1 receptor (c-fms) but
express much higher levels of ICAM-1 and LFA-3 adhesins.
(iii) In functional assays, dendritic cells are at least 100 times
more potent than monocytes or lymphocytes in stimulating the
primary mixed leukocyte reaction. These properties help make
the trace subset of dendritic cells more amenable to further
functional and clinical studies.
Prior reports (1-9) have described antigen-presenting dendritic
cells in human blood. These cells resemble more extensively
studied counterparts in the lymphoid tissues of other species.
In particular, blood dendritic cells express high levels of major
histocompatibility complex (MHC) products and actively
stimulate primary T-cell responses to transplantation antigens
(3, 4, 10-12). When we began to study dendritic cells in
individuals infected with human immunodeficiency virus type
1, we encountered difficulties in obtaining sufficiently high
purity and in monitoring the purification. To date, only partial
purification of dendritic cells (<1% of blood mononuclear
cells) has been achieved, and there has been no detailed study
with the fluorescence-activated cell sorter (FACS). Here we
present an approach for preparing highly enriched popula-
tions, which we then study to describe their distinctive mo-
tility, phenotype, and function.
METHODS
Culture Medium. RPMI medium 1640 supplemented with
5-10% heat-inactivated normal human AB' serum, 1 mM
glutamine, 50 ,uM 2-mercaptoethanol, penicillin at 100 units/
ml, and streptomycin at 100 ,ug/ml was used.
Cell Separation. See Fig. 1. Granulocytes were isolated
from heparinized whole blood (13) and used immediately. For
mononuclear cells, the blood or leukocyte-enriched "buffy
coat" was layered onto Ficoll-Paque (1.0777 g/ml; Pharma-
cia) and sedimented at 1000 x g for 20 min at 21°C. Mono-
nuclear cells were harvested from the interface and sedi-
mented three times in phosphate-buffered saline (PBS) with-
out Ca2' and Mg2+ to remove platelets (first at 650 x g then
twice at 235 x g). T lymphocytes were separated by rosetting
at 4°C with neuraminidase-treated sheep erythrocytes fol-
lowed by Ficoll-Paque sedimentation. T cells were recovered
from the pellet by lysing the erythrocytes in NH4Cl and
washing twice in RPMI 1640 (6). The T-cell-depleted eryth-
rocyte rosette-negative (ER-) fraction was washed twice in
RPMI 1640 and cultured at 3-5 x 106 cells per ml at 37°C for
36 hr in 100-mm tissue culture dishes. After culture, most of
the cells could be collected from the plates. By reculturing the
cells twice for 30-40 min at 37°C on fresh dishes, the
monocytes were selectively attached. Nonadherent cells
were "panned" once or twice on bacteriologic plastic dishes
coated with human immunoglobulin to remove residual Fc
fragment receptor (FcR)-bearing monocytes (6). To recover
the adherent monocytes, the dishes were washed three times
with cold PBS and cultured with fresh medium for 3-4 hr, at
which point the monocytes were easily dislodged from the
surface. The monocyte- and T-cell-depleted fraction (5-8 x
106 cells per ml; 3-4 ml) was layered onto 2.5-ml columns of
hypertonic 14.5% metrizamide (dissolved in RPMI 1640 with
10% heat-inactivated fetal calf serum) in 15-ml conical tubes
and sedimented at 650 x g for 10 min at room temperature
(14). The dendritic-cell-enriched interface was separated
from the B- and natural killer (NK)-cell-enriched pellet. Both
fractions were washed in two successively less hypertonic
washes to return the cells to isotonicity [RPMI 1640 supple-
mented with 10% fetal calf serum and 40 mM NaCl (wash 1)
or 25 mM NaCl (wash 2)].
CD45R Panning. The dendritic cell fraction was treated
with a monoclonal antibody (mAb) specific for restricted
CD45 antigen (CD45R) (Leul8; Becton Dickinson) at 20 ,ul of
mAb per 106 cells in 1-2 ml of culture medium and on ice for
45-60 min. The cells were washed four times and sedimented
twice at 50 x g (5 min, 4°C) onto plastic dishes coated with
goat antibodies to mouse immunoglobulin (10). The plates
were swirled gently prior to harvesting the dendritic cell
preparation that was depleted of CD45R+ contaminants.
Cel Sorting. An alternative final step in the dendritic cell
enrichment procedure was to use the FACS. Cells in the
metrizamide low-density fraction were combined with 20 ,ul of
fluorescein-conjugated Leui8 per 106 cells in 1-2 ml ofmedium
on ice for 45-60 min. The cells were washed four times and
Abbreviations: MHC, major histocompatibility complex; ER, eryth-
rocyte rosette; NK, natural killer; mAb, monoclonal antibody; MLR,
mixed leukocyte reaction; APC, antigen-presenting cell(s); FcR, Fc
fragment receptor; C3R, complement component 3 receptor; IL-2R,
interleukin 2 receptor; CSF, colony-stimulating factor.
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FIG. 1. Flow plan and yields of the dendritic cell (DC) isolation
protocol. (Left) Outline of the steps in the isolation protocol. (Right)
Mean and range of cell yields in two sets of six experiments. Each
set (A, B) utilized a different final step.
sorted on a FACStar Plus (Becton Dickinson). Large (high
forward scatter) Leul8- cells were selected as the dendritic
cells. A "cocktail" of six phycoerythrin-conjugated mAb to
other cell types (Leu4, Leulic, Leul2, Leul6, Leul9, and
LeuM3; Becton Dickinson), each added at 10 ,ul per 106 cells,
could be used instead of Leul8. Dendritic cells were again
collected as the large unlabeled cells.
FACS Analyses. Unless otherwise stated, populations were
stained with mouse mAbs followed by fluorescein-conjugated
goat antibodies to mouse immunoglobulin. The cells were
analyzed on a FACScan instrument (Becton Dickinson).
Mixed Leukocyte Reaction (MLR). Stimulators (antigen-
presenting cells, APC) for the MLR were derived from the
separation protocol. The APC were irradiated [3000 rads (1
rad = 0.01 Gy) from '37Cs] and added in graded doses to 1.5
x 105 allogeneic or syngeneic T cells in 96-well flat-bottom
tissue culture plates in 0.2 ml of medium per well. Prolifer-
ation was measured by the uptake of [3H]thymidine [1 p.Ci per
well, 6 Ci/mmol (1 Ci = 37 GBq)] added for 8 hr on the 5th
day. The responses are reported as the mean cpm of tripli-
cates, omitting the standard deviations, which were <10%.
Motility and Morphology. Morphology and motility were
monitored at 370C on an incubated-stage inverted microscope
(Nikon Diaphot) with a video camera, a video cassette
recorder, and monitor attached.
RESULTS
Method and Monitoring Criteria for Enriching Human
Blood Dendritic Cells. Fig. 1 outlines a sequence of steps that
reliably enriched the trace population of human blood den-
dritic cells. Using protocol A, we obtained 3.5 x 106 cells that
were 30-60% dendritic cells. Protocol B allows further
enrichment (80-90%) by using the CD45R panning method
discussed below. At the same time, three other dendritic
cell-depleted populations were obtained: T cells by erythro-
cyte rosetting, monocytes by plastic adherence after 1-2 days
in culture, and a mixture ofB and NK cells by sedimentation
in metrizamide (Fig. 1).
Two approaches were used to document the progressive
enrichment of dendritic cells. First, observation of live prep-
arations best revealed an irregular shape and motility, as
outlined below. Second, cytofluorography displayed the en-
richment of large cells (high forward scatter) that failed to
stain with a cocktail ofmAbs to other types ofleukocyte (Fig.
2: CD14, monocytes; CD16 and CD56, NK cells; CD19 and
CD20, B cells; and CD3, T cells). Such large "null" cells
were not detected in the other fractions (Fig. 2 A, B, E).
To further purify the dendritic cells-i.e., to 80-90% purity
or more-we took advantage of a finding that dendritic cells
lack CD45R, but the majority of contaminants in the metri-
zamide low-density fraction express high levels. Contami-
nants could then be depleted by panning with the CD45R
mAb, Leul8 (Fig. 2 -H). Alternatively, one could sort the
dendritic cells to an even higher purity on a FACS by marking
the contaminants either with anti-CD45R or with the cocktail
of mAbs (Fig. 3A). Sorting provided the highest purity, but
panning provided higher yields of dendritic cells.
In summary, the above method enriched a trace subset of
large, "null," irregularly shaped cells. This procedure can be
used to isolate dendritic cells from small volumes of blood
(60-120 ml) with yields proportional to those from buffy coat
fractions (450-500 ml starting blood volume) (not shown).
FIG. 2. (A-D) The four major cell populations
generated from a typical separation protocol exper-
iment. All populations were stained with the cock-
tail of mAbs to T-cell, B-cell, NK-cell, and mono-
cyte markers. x-Axis, forward light scatter; y-axis,
fluorescence intensity (logarithmic scale, 4 powers
of 10). (A) ER+/T-cell enriched. (B) Adherent/
monocyte-enriched. (C) Metrizamide high density/
B- and NK-cell-enriched. (D) Metrizamide low den-
sity/dendritic-cell-enriched. (E-H) Dendritic cell
enrichment by using CD45R panning. All popula-
tions were stained with the mAb cocktail as above.
(E) ER-, monocyte-depleted population. (F) Me-
trizamide high-density population. (G) Metriza-
mide low-density population. (H) Panned
(CD45R-) enriched dendritic cell population.
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Motility of Dendritic Cells. Each dendritic cell continually
extended and reoriented processes, usually as lamellipodia or
veils (Fig. 4). Individual veils extended 10-30 ,um and could
pass through an arc of 180'C in 30-60 sec. This pattern of veil
formation and movement has been noted previously (15, 16).
Our experiments indicated that this is a feature of all dendritic
cells and is not seen in monocytes and lymphocytes studied
in parallel.
Surface Composition of Dendritic Cells: FACS Analyses.
With the populations that we obtained, it was feasible to
analyze surface antigens with a large panel ofmAbs (Table 1)
and the FACS (Fig. 3B). Several conclusions were evident.
(i) Dendritic cells had high levels of surface MHC products,
including all three MHC class II loci (HLA-DR, -DQ, and
-DP) and the class II-associated invariant chain. Monocytes,
isolated from the identical cultures, expressed 1/10th to
1/100th as much HLA-DR and had low or undetectable levels
of HLA-DQ, HLA-DP, and the invariant chain (not shown).
(ii) Dendritic cells either lacked or expressed very low levels
of most T-cell, B-cell, NK-cell, and phagocyte (monocyte
and granulocyte)-restricted markers, but all cells expressed
comparable levels of the leukocyte common antigen, CD45.
(iii) Dendritic cells had a distinct repertoire of surface recep-
tors and adhesion molecules. All known Fc and complement
component 3 (C3) receptors (FcR and C3R) were weak or
absent, as was the c-fins receptor for colony-stimulating
A
Pro-Soi DC Enviched DC Depleted
B
Control M-R LPA-3'
CL 4 HLA-DQ ICAM-1
1kC-fins HLA-DP 11I
A CD14 nr. CIl
CDw2OL2 CI
FIG. 3. (A) FACS separation of dendritic cells (DC) on the basis
of CD45R expression. x-Axis, forward light scatter; y-axis, fluores-
cence intensity (logarithmic scale, 4 powers of 10). Dendritic cells are
sorted as large CD45R- cells. (B) Highly enriched (sorted) dendritic
cells stained for key surface markers. x-Axis, fluorescence intensity
(logarithmic scale, 4 powers of 10); y-axis, frequency.
factor (CSF)-1 or macrophage CSF, but the p55 interleukin 2
receptor (IL-2R) (CD25) was present. Adhesion molecules
were abundant, including ICAM-1 (CD54), LFA-3 (CD58)
and several integrins (f31/CD29, .32/LFA-1/CD11a, and
p150/90/CD11c). In contrast, monocytes expressed CD32
FcR, CD11b C3R, and CSF-1R, and had much lower levels
of ICAM-1, LFA-3, and IL-2R. (iv) The phenotype of den-
dritic cells was uniform in that most markers were either
completely absent or expressed to a comparable degree.
MLR Stimulating Activity of Enriched Populations of Blood
Mononuclear Cells. The APC function of the populations
prepared as in Fig. 1 were compared by testing stimulatory
capacity for allogeneic T lymphocytes in the primary MLR.
As one enriched for dendritic cells, stimulatory capacity was
markedly enhanced (Fig. 5). Bulk blood mononuclear cells
were 1/30th to 1/100th as active as enriched dendritic cells.
Monocyte, B-, and T-cell populations were significantly less
stimulatory in the MLR than bulk mononuclear cells. Only
dendritic cells induced a syngeneic MLR (Fig. 5 Right).
DISCUSSION
Dendritic cells can be isolated by sequentially removing each
ofthe other cell types in blood. Our method differs from prior
methods in the degree of enrichment achieved and in two
additional respects. First, all the blood mononuclear cells are
retained in either dendritic cell-depleted or -enriched popu-
lations. Second, each fraction can be monitored with the
FACS or by direct observation looking for large, "null,"
class II-MHC-rich cells or for motile dendritic cells.
The strategy (Fig. 1) utilizes more than one negative
selection technique to deplete each cell type. This is neces-
sary, because dendritic cells are outnumbered 30- to 300-fold
by any other mononuclear cell type in blood. T-cell depletion
occurs through erythrocyte rosetting, sedimentation in me-
trizamide, and panning or sorting with mAb; monocyte
depletion requires a combination of plastic adherence and
FIG. 4. Motility of dendritic cells. Four frames of two dendritic
cells taken at 10-sec intervals. Note the rapid changes in morphology
and veil position. (x380.)
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Table 1. mAbs and their reactivities with various cell populations
Staining














































































































































Leul9 - - - +/++
HNK-1 - - - +/++ -
s; B&NK, B and NK cells. The levels of mAb staining on the various cell populations obtained as in Fig. 1 are indicated
etectable staining; tr (trace), <5 x background; +, 5-15 x background; ++, 15-100 x background; +++, >100 x
i of staining is indicated with division of symbols by /. A blank means not done. mAbs are described in ref. 17.
FcR panning; and B- plus NK-cell depletion depends upon
metrizamide sedimentation and a final panning or sorting
step. At no point is there positive selection for cells with the
unusual motility and phenotype of dendritic cells. The fact
that such cells emerge upon negative selection supports the
conclusion that they are a distinct element in human blood.
For a variety ofreasons, it was advantageous to separate the
monocytes from the dendritic cells after 36 hr in culture. (i)
The monocyte is the main cell type that adheres firmly but
reversibly to plastic after culture. This allows monocytes to be
separated and subsequently recovered largely free from den-
dritic cells, many of which are adherent in fresh isolates. (ii)
During culture, the phagocytic monocytes remove residual
erythrocytes and other debris that are present after the T-cell
depletion. Debris is a major contaminant of populations that
are enriched by flotation on dense columns. (iii) The presence
of monocytes or monocyte-derived factors seems to improve
the viability of the final dendritic cell population. The criteria
in this paper for identifying dendritic cells can now be used in
fresh isolates of human blood.
The important functional role of dendritic cells is their
initiation of primary responses such as the MLR. The data in
Fig. 5 show the greatest differences that have been observed
between dendritic cells and other cell types, presumably
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Stimulator-to-responder ratio in MLR
FIG. 5. MLR stimulatory function of the different cell popula-
tions isolated through the enrichment protocol. Typical reciprocal
syngeneic and allogeneic MLRs from two donors (A and B) are
shown. Responder cells (resp) are purified T lymphocytes. The
stimulators (stim) were as follows: o, bulk mononuclear cells; a, ER'
T cells; r, monocyte-enriched cells; ., metrizamide high-density
cells; v, metrizamide low-density cells; and i, CD45R-, metrizamide
low-density cells.
because of the greater purity of each population. In a recent
report, granulocyte-macrophage CSF enhanced dendritic
cell viability (18). This conclusion is puzzling, however,
because the MLR-stimulating function of the dendritic cells
in that report was only twice that ofmonocytes or other cells.
Because of the difficulty in enriching blood dendritic cells,
it has not been possible previously to obtain a detailed
semiquantitative analysis of their surface. The results of such
an analysis are summarized in Table 1. The expression of high
levels of all MHC class II (HLA-DR, -DQ, -DP) products is
the most distinctive feature and helps to explain the observed
potency of dendritic cells as APC. Given the high levels of
HLA-DP, -DQ, -DR, and invariant chain, it is possible to
generate mAbs that appear to be specific for dendritic cells,
but are instead directed to these products. The repertoire of
dendritic cell surface receptors is also unique. FcR (CD16,
CD32, CD64) and C3R (CD11b, CD21, CD35), which are
involved in particle binding and uptake, are all weak or
absent, as is the lineage restricted c-fms receptor for mac-
rophage CSF-1. p55 IL-2R (CD25) was detected by using any
of the four mAbs we tested. The dendritic cells do not grow
upon addition of interleukin 2 (1-100 units/ml), however.
Dendritic cells have the highest levels among blood leuko-
cytes of the adhesins CD29 (831-integrin), CD11a (LFA-1),
CD54 (ICAM-1), and CD58 (LFA-3). Since adhesins are
subject to up-regulation by cytokines, it is possible that blood
dendritic cells are migrating from tissues where they have
been exposed to such stimuli. The presence of adhesins helps
to explain the capacity of dendritic cells to aggregate large
numbers of T cells for long periods (10, 19).
Only granulocytes in blood move as rapidly and form such
large lamellipodia as dendritic cells. However, granulocyte
veils typically extend in a directed fashion in response to a
chemotactic stimulus (20). Our enrichment protocol should
facilitate the search for substances that influence dendritic
cell movements. The potency ofdendritic cells as APC might
be augmented by rapid and vigorous movement, which would
facilitate the sampling and formation of contacts with T
lymphocytes.
We thank Mary T. Crowley for her expertise and assistance with
cell sorting and William Swiggard for his helpful comments. Our
thanks also go to the following colleagues for providing mAbs for this
study: W. Knapp (University of Vienna), N. Romani (University of
Innsbruck), S. M. Fu (University of Virginia, Charlottesville), and
T. A. Springer (Dana-Farber Cancer Institute, Boston). This work
was supported by National Institutes of Health Grant A124540
(R.M.S.) and Training Grant GM07982-08 (P.S.F.) and by a grant
from the David C. Scott Foundation (P.S.F.).
1. Van Voorhis, W. C., Hair, L. S., Steinman, R. M. & Kaplan,
G. (1982) J. Exp. Med. 155, 1172-1187.
2. Van Voorhis, W. C., Steinman, R. M., Hair, L. S., Luban, J.,
Witmer, M. D., Koide, S. & Cohn, Z. A. (1983) J. Exp. Med.
158, 126-145.
3. Knight, S. C., Farrant, J., Bryant, A., Edwards, A. J., Bur-
man, S., Lever, A., Clark, J. & Webster, A. D. B. (1986)
Immunology 57, 595-603.
4. Kuntz-Crow, M. & Kunkel, H. G. (1982) Clin. Exp. Immunol.
49, 338-341.
5. Santiago-Schwartz, F., Bakke, A. C., Woodward, J. G.,
O'Brien, R. L. & Horwitz, D. A. (1985) J. Immunol. 134,
779-785.
6. Young, J. W. & Steinman, R. M. (1988) Cell. Immunol. 111,
167-182.
7. Poulter, L. W., Campbell, D. A., Munro, C. & Janossy, G.
(1986) Scand. J. Immunol. 24, 351-357.
8. Gaudernack, G. & Bjercke, S. (1985) Scand. J. Immunol. 21,
493-500.
9. Vakkila, J., Lehtonen, E., Koskimies, S. & Hurme, M. (1987)
Immunol. Lett. 15, 229-236.
10. Flechner, E., Freudenthal, P., Kaplan, G. & Steinman, R. M.
(1988) Cell. Immunol. 111, 183-195.
11. Van Voorhis, W. C., Valinsky, J., Hoffman, E., Luban, J.,
Hair, L. S. & Steinman, R. M. (1983) J. Exp. Med. 158,
174-191.
12. Young, J. W. & Steinman, R. M. (1990) J. Exp. Med. 171,
1315-1330.
13. Ferrante, A. & Thong, Y. H. (1980) J. Immunol. Methods 36,
109-117.
14. Knight, S. C., Mertin, J., Stackpoole, A. & Clark, J. (1983)
Proc. Natl. Acad. Sci. USA 80, 6032-6035.
15. Steinman, R. M. & Cohn, Z. A. (1973) J. Exp. Med. 137,
1142-1162.
16. Drexhage, H. A., Mullink, H., de Groot, J., Clarke, J. &
Balfour, B. M. (1979) Cell Tissue Res. 202, 407-430.
17. Knapp, W. (1989) Leucocyte Typing IV: White Cell Differen-
tiation Antigens (Oxford Univ. Press, Oxford).
18. Markowicz, S. & Engleman, E. G. (1990) J. Clin. Invest. 85,
955-961.
19. Inaba, K., Young, J. W. & Steinman, R. M. (1987) J. Exp.
Med. 166, 182-194.

















Proc. Natl. Acad. Sci. USA 87 (1990)
D
ow
nl
oa
de
d 
at
 R
oc
ke
fe
lle
r 
U
ni
ve
rs
ity
 L
ib
ra
ry
 o
n 
Ju
ly
 2
1,
 2
02
0 
